INTRODUCTION
It is well established that maternal folate deficiency or polymorphisms in genes required for folate metabolism are associated with an increased risk of congenital abnormalities in humans, including intrauterine growth restriction, cardiovascular and placental abnormalities, and neural tube defects (NTDs). However, conflicting reports have been published showing association and nonassociation between polymorphisms in folate pathway genes and risk for specific congenital malformations (e.g., NTDs [Rampersaud et al., 2003; van der Put et al., 1995] ). This is reinforced by studies whereby mutations in mouse genes encoding proteins required for folate transport and metabolism do not appear to recapitulate the range of congenital abnormalities produced by maternal folate deficiency in humans (Chen et al., 2001; Deng et al., 2008; Gelineau-van Waes et al., 2008; Pickell et al., 2009; Piedrahita et al., 1999; Swanson et al., 2001) . As a result, the underlying mechanism through which folate metabolism acts during development may be more complex than once thought and remains poorly understood.
Folate is a carrier of methyl groups destined for downstream targets, including homocysteine for methionine synthesis in a reaction that links the folate and methionine cycles ( Figure 1A ). The main circulating folate, 5-methyltetrahydrofolate (5-methyl-THF) (Smith et al., 2006) , is generated by methylenetetrahydrofolate reductase (MTHFR) (Ghandour et al., 2004; Hart et al., 2002) . Its methyl group is exclusively transferred by methionine synthase (MS, encoded by the gene Mtr) to homocysteine to form methionine and tetrahydrofolate (Shane and Stokstad, 1985) . In turn, methionine is a precursor to S-adenosylmethionine (S-AdoMet), which serves as the methyl donor for dozens of cellular substrates, including proteins, RNA, and DNA (Ghandour et al., 2002; Jacob et al., 1998; Wainfan et al., 1975) . Consequently, folate and methionine metabolism are important for successful pregnancy. In mammals, methionine synthase reductase (Mtrr) is responsible for the activation of MS through the reductive methylation of its vitamin B 12 cofactor (Yamada et al., 2006) . Therefore, Mtrr is required for normal progression of the folate and methionine cycles.
Here, we demonstrate that a hypomorphic mutation in the mouse Mtrr gene (Mtrr gt In particular, the Mtrr genotype of either maternal grandparent dictates the developmental potential of their wild-type grandprogeny. These effects are associated with altered DNA methylation patterns and two distinct phenotypes: intrauterine growth defects and congenital malformations that are separable through embryo transfer experiments. We propose that the Mtrr mutant mouse line provides a robust model for studying epigenetic transmission of developmental disorders between generations.
RESULTS

Mtrr gt Mutation Causes Abnormal Folate Metabolism in Mice
To explore the relationship between folate metabolism and development, we generated Mtrr-deficient mice using embryonic stem cells containing a randomly inserted gene-trap (gt) vector in the Mtrr gene locus ( Figure 1B) . We verified the insertion of the gt vector into intron 9 of the Mtrr locus by Southern blotting and DNA sequencing (data not shown) and were able to distinguish between Mtrr +/+ , Mtrr +/gt , and Mtrr gt/gt mice by a three primer PCR using primers that flanked the gt insertion site combined with a primer specific to the gt vector ( Figure 1B) . mRNA levels ( Figure 1C ). As a result, Mtrr gt is a knockdown allele. Increased levels of plasma homocysteine are used as an indicator of folate deficiency (Hague, 2003; Piedrahita et al., 1999) . Therefore, using tandem mass spectrometry, we measured plasma total homocysteine concentrations in adult female and male Mtrr gt/gt mice and detected an average of 23.3 ± 5.5 mM (mean ± SD) and 11.0 ± 3.6 mM total homocysteine, respectively. These values were 3.3-to 3.7-fold greater than in Mtrr +/+ littermates (females: 7.0 ± 0.6 mM [p < 0.005]; males: 4.6 ± 0.3 mM [p < 0.05]) ( Figure 1D ) and are comparable to mouse models with genetic mutations in other folate metabolic enzymes (summarized by Elmore et al., 2007) . Elmore et al. (2007) also showed increased liver 5-methyl-THF, reduced plasma methionine, and reduced heart AdoMet/AdoHcy ratio in Mtrr-deficient adults compared to wild-type littermates. Altogether, these data reveal that Mtrr gt mice are an appropriate model for studying the impact of abnormal folate metabolism. Figure 2B ), in contrast to 95.7% of the conceptuses from C57Bl/6 litters ( Figure 2A ). Similar numbers of resorptions were present, suggesting that there was no difference in embryonic lethality occurring prior to E10.5. However, the remaining conceptuses from the mutant matings showed severe congenital malformations not present in control litters, ranging from developmental delay to NTDs and heart defects. Surprisingly and consistent with Mendelian ratios at weaning, genotyping results indicated that all embryonic genotypes, including wild-type, were equally affected ( Figure 2C ).
Phenotypes of Progeny from
We found that 20% of embryos at E10.5 were developmentally delayed by $0.5-2.0 days (i.e., contained <30 somite pairs) (Figures 2B, 2E, and 2F and Table S1 available online), although they otherwise appeared normal. In addition, 12.9% of conceptuses exhibited one or more congenital abnormality ( Figure 2 and Table S1 ). Among these, we observed heart defects, including pericardial edema ( Figure 2G ), reversed cardiac looping ( Figure 2I ) and enlarged hearts that were thicker and disproportionate in size ( Figure 2J ), abnormal placental development whereby chorioallantoic attachment was eccentric ( Figure 2L ) or failed to occur (data not shown), and hemorrhaging ( Figures  2M and 2N ). NTDs were also observed, including neural tubes that failed to close by the appropriate developmental stage in the cranial region ( Figure 2P ). These defects are reminiscent See also Figure S1 and Table S1 .
of embryos at E10.5 from Mthfr +/À intercrosses (Pickell et al., 2009 Figure S1 ).
Pedigree analysis of these Mtrr +/+ intercrosses revealed that Statistics: independent comparison of phenotypic frequencies per litter of each pedigree and C57Bl/ 6 using Mann-Whitney test.
(C) Average embryo crown-rump lengths (± SEM) (left) and average placental weights (± SEM) (right) from conceptuses staged as E10.5 (i.e., 30-40 somite pairs) per pedigree (n = 51-89 conceptuses). Statistics: comparison to C57Bl/6 using independent t test.
(D) Representative images of normal, growthrestricted (GR) and growth-enhanced (GE) wildtype embryos at E10.5. Scale bars, 1 mm.
(E) Distribution of crown-rump lengths in E10.5-staged embryos (n = 51-89 embryos). Black dotted line, mean; gray dotted lines, two SD from mean. *p < 0.05, **p < 0.01, and ***p < 0.005. See also Figure S2 and Table S2. pregnancies with abnormal litters almost always had Mtrr +/gt maternal grandparents ( Figures 2R and S1 ). This implied that normal embryonic development might be associated with a grandparental, and not parental, Mtrr gt mutation.
To verify that a paternal Mtrr gt allele did not contribute to the defects, we crossed Mtrr +/gt males with C57Bl/6 females and assessed the litters at E10.5 (n = 10 litters) (Figures 3A, 3B, and S2). All conceptuses were normal with no obvious developmental delay or defects, except one conceptus with a placenta defect. Because the Mtrr +/gt males were derived from Mtrr +/gt parents, these data indicated that neither the paternal nor the paternal grandparents' Mtrr genotype significantly affected development at this stage.
Next, we examined the specific effect of the maternal grandparental Mtrr gt mutation on embryonic development by crossing Figure 3B ). Crown-rump length measurements of embryos within the normal developmental range for E10.5 (30-40 somite pairs) revealed that, on average, these embryos were significantly smaller than C57Bl/6 embryos ( Figure 3C ). In fact, a large proportion of these so-called ''normal'' embryos were growth restricted (22.0% and 22.5% of conceptuses from Mtrr +/gt maternal grandmothers and grandfathers, respectively, as defined as more than two SDs below the mean length of C57Bl/6 embryos) ( Figures 3D and 3E ). However, some embryos were actually growth enhanced, particularly those derived from Mtrrdeficient maternal grandfathers (7.9% growth enhanced, p < 0.05) ( Figures 3B, 3D , and 3E). The presence of growth phenotypes did not correlate with litter size (Table S2) . Beyond growth defects, the remaining affected conceptuses were either developmentally delayed or had severe defects ( Figures 3A and 3B ), similar to those described above, including NTDs, heart abnormalities, placental defects, and hemorrhages ( Figure S2 ). The rates of resorption were not significantly different from C57Bl/6 controls ( Figure 3B ). Interestingly, some litters were more sensitive to grandparental Mtrr deficiency than others because a proportion of the litters appeared normal, whereas up to 100% of conceptuses were affected in other litters ( Figure 3A) . Figure 4A ), indicating that the brain might be spared from reduced methyl group availability. DNA hypomethylation was also evident in the livers and uteri of adult wild-type littermates (40%-62% of C57Bl/6 levels; Figure 4A ), further emphasizing a nongenetic influence in the Mtrr gt model. These data support an epigenetic effect of folate metabolism because the dysregulation of DNA methylation precedes the appearance of developmental phenotypes in the Mtrr gt model.
Next, we assessed the effects of maternal grandparental Mtrr deficiency on global DNA methylation in their wild-type grandprogeny at E10.5. Although we did not observe significant differences in the phenotypically normal or growth-restricted embryos derived from an Mtrr +/gt maternal grandparent, there was significant global DNA hypomethylation in the corresponding placentas (53% or 63%-66% of C57Bl/6 levels, respectively) ( Figure 4C ). This implied that the placental epigenetic landscape was altered. Global DNA methylation was also reduced in wildtype placentas derived from Mtrr +/gt fathers (50% of C57Bl/6 levels) ( Figure 4C ), which further supports an epigenetic mechanism because it shows that altered DNA methylation precedes the appearance of developmental phenotypes. For example, wild-type daughters of an Mtrr +/gt male developed normally despite having hypomethylated placental DNA, and yet in adulthood, these females produce abnormal progeny with hypomethylated placentas ( Figures 3A, 3B , and 4C).
Placentas of Wild-Type Grandprogeny Are Epigenetically Unstable at E10.5 Imprinted loci have previously been used as a model to study epigenetic stability during development (Messerschmidt et al., 2012) . It is well known that imprinted genes are regulated by DNA methylation at differentially methylated regions (DMRs) in a parental-origin specific manner. The majority of known imprinted genes is expressed in fetally derived extraembryonic tissue within the placenta and not in the maternal decidua and is required for normal placental development (Coan et al., 2005; Hemberger, 2010; Tunster et al., 2013) . To determine the degree of epigenetic instability in grandprogeny of an Mtrr +/gt maternal grandparent, we analyzed imprinted loci for alterations in DNA methylation and gene expression in wild-type placentas at E10.5. Using the bisulfite pyrosequencing method, we assessed DNA methylation at key CpG sites (n = 143) within 20 different DMRs (Table S3 ). Analysis of placentas of wild-type conceptuses derived from Mtrr +/gt fathers revealed only a few CpG sites (10/ 143 CpGs in 6/20 DMRs) that were significantly abnormally methylated with an average methylation change (± SEM) of 2.0% ± 0.2% compared to C57Bl/6 levels ( Figures 4D, 4E , and 5 and Table S3 ). This implied that these placentas were epigenetically quite stable, which is consistent with the absence of phenotypes in these litters (Figure 3 ). Conversely, a large proportion (45.0%-70.0%) of the DMRs assessed in wild-type placentas of phenotypically normal, growth-restricted, and severely affected grandprogeny derived from either Mtrr +/gt maternal grandparent had CpG site methylation levels that were statistically different from C57Bl/6 ( Figures 4E and 5 and Table S3 ). The majority of the significantly affected CpG sites were hypermethylated ( Figure 4F ). The placentas of growth-restricted and severely affected conceptuses had an average CpG methylation change that was significantly larger (5.4%-5.5% [p < 0.05] and 6.6%-7.2% [p < 0.005] of C57Bl/6 levels, respectively) compared to phenotypically normal conceptuses from the same pedigree (3.0%-3.3% of C57Bl/6 levels) (Figures 4D and  5 and Table S3 ), indicating a positive correlation between epigenetic instability and the severity of the phenotype. Furthermore, some DMRs were more sensitive to grandparental Mtrr deficiency than others because a proportion had only one CpG site with significantly aberrant methylation, whereas other DMRs had up to 100% of CpG sites with abnormal methylation that were statistically different from C57Bl/6 controls (Figure S3A ). These overall DNA methylation trends were further exacerbated in Mtrr gt/gt placentas ( Figures 4D-4F , 5, and S3A
and Table S3 ).
To determine whether the placental epigenetic instability observed was functionally important, we used qRT-PCR to measure the expression of imprinted genes specifically regulated by methylation at these DMRs in the grandprogeny at E10.5 (Table  S3 ). The majority of misexpressed genes was statistically downregulated in a phenotype-dependent manner compared to C57Bl/6 placentas ( Figure 4G and Table S3 ), which supports the overall trend of DMR hypermethylation. Importantly, more misexpressed genes were associated with abnormal DMR methylation rather than normal DMR methylation. This occurred regardless of the conceptus' phenotype and whether it was derived from an Mtrr +/gt maternal grandmother or grandfather ( Figures 4H and 5) . Together with the observation that there were a considerable number of abnormally methylated DMRs associated with normally expressed genes ( Figure 4H ), we conclude that dysregulation of DNA methylation likely preceded the changes in gene expression. The instances of gene (C) Relative global 5mC levels (mean ± SEM) in placentas and embryos derived from the pedigree denoted in (B) compared to C57Bl/6 (n = 5-10; normalized to 1). Independent t tests compared C57Bl/6 to each phenotype/pedigree. (D) Average change in CpG methylation (%) in imprinted DMRs compared to C57Bl/6 controls (± SEM). Placentas of conceptuses derived from the pedigree denoted in (B) were assessed. Only CpG sites with significant methylation changes were included. Growth-restricted and severely affected placentas were compared to phenotypically normal placentas within the same pedigree using an independent t test. (E) A heatmap indicating average methylation change (%) at individual CpG sites in each DMR compared to C57Bl/6. Placentas of phenotypically normal (n), growth-restricted (gr) and severely affected (a) conceptuses (generation III) from each pedigree were assessed. (F and G) The number of (F) DMRs with significant hyper-or hypomethylation and (G) imprinted genes with significant up-or downregulated RNA expression in placentas of conceptuses from the designated pedigree and phenotypic group compared to C57Bl/6. (H) An association analysis between CpG methylation in DMRs and RNA expression of corresponding imprinted genes. Abnormal DMR methylation: R 1 CpG site with significantly different methylation compared to C57Bl/6. Abnormal RNA expression: significantly different from C57Bl/6. n = 3-10 placentas/phenotype/ pedigree in panels (C)-(H). Ab, abnormal; Exp, expression; Meth, methylation; N, normal. x p = 0.07, *p < 0.05, **p < 0.01, and ***p < 0.005. See also Figure S3 and Table S3. misexpression associated with normal DMR methylation (Figure 4H) were likely the consequence of secondary effects of Mtrr deficiency, including the dysregulation by upstream genes affected by abnormal methylation (e.g., transcription factors or noncoding RNA). Altogether, this suggests a hierarchy of events: an Mtrr gt mutation in either maternal grandparent leads to epigenetic instability in important regulatory regions in placentas of their wild-type grandprogeny, which may, in turn, cause gene misexpression leading to developmental phenotypes. As with the global methylation patterns, DMR methylation and gene expression (e.g., the Igf2/H19 locus) in wild-type embryos at E10.5 was not significantly different from controls ( Figures  4C and S3B and Table S3 ). Important changes in DNA methylation and gene expression of specific cell populations might not be apparent when assessing whole embryos. Alternatively, placental cells may be more susceptible than embryonic cells to the intergenerational effects of abnormal folate metabolism. A direct paramutation effect (Rassoulzadegan et al., 2006 ) is unlikely because normal levels of wild-type Mtrr mRNA were present in Mtrr +/+ placentas and embryos at E10.5 derived from either an Mtrr +/gt parent or grandparent compared to C57Bl/6 controls, regardless of phenotype ( Figure S4 ).
Congenital Abnormalities in Wild-Type Grandprogeny Are due to Epigenetic Inheritance
To better understand the causes of the developmental abnormalities observed in the grandprogeny, we performed an embryo transfer experiment (Figures 6 and S5 ) to distinguish between an epigenetic effect on the ability of females in generation II to carry normal pregnancies (maternal environment) versus the effect on gametes (direct epigenetic inheritance). Wild-type preimplantation embryos derived from pedigrees with one Mtrr +/gt maternal grandparent and a wild-type mother were collected at E3.25, immediately prior to the initiation of DNA remethylation during epigenetic reprogramming (Saitou et al., 2012) . Same-stage C57Bl/6 embryos were used as controls. Embryos were transferred into the uteri of pseudopregnant B6D2F1 females and allowed to develop until E10.5. If a phenotype was absent, then an abnormal maternal environment in the original donor mother (i.e., generation II) was the cause of this defect. However, persistence of a phenotype indicates that this defect occurred independent of the maternal environment. Remarkably, the embryo transfer results suggested that the growth defects and the congenital malformations were due to separate epigenetic mechanisms. Growth restriction and developmental delay phenotypes were not observed in the transferred litters derived from Mtrr +/gt maternal grandmothers (n = 36 conceptuses) and Mtrr +/gt maternal grandfathers (n = 60 conceptuses) (Figures 6 and S5 ), indicating that the B6D2F1 maternal environment rescued the growth phenotypes. In fact, we observed an increased frequency of growth enhancement (16.7%-30.6% of conceptuses) compared to controls (4.7% [p % 0.05]; n = 43 implantation sites) ( Figure 6 ). By contrast, congenital abnormalities, including neural tube, heart, and placenta abnormalities, persisted in 8.3%-15.0% of the transferred grandprogeny at E10.5 (Figures 6 and S5) . No severe abnormalities were apparent in the transferred C57Bl/6 conceptuses. Therefore, Mtrr deficiency results in epigenetic effects both on their daughter's maternal environment and on their gametes leading to defective fetal and placental development in their grandprogeny. In support of this, we observed the persistence of severe abnormalities, but not developmental delay or significant frequencies of growth restriction at E10.5, in generations IV and V derived from an Mtrr +/gt maternal ancestor (Figures 7 and S6 ).
This further signifies that abnormal folate metabolism contributes to epigenetic inheritance through the germline.
DISCUSSION
We have conducted highly controlled experiments and genetic crosses to show that folate metabolism has distinct transgenerational epigenetic functions that are responsible for specific developmental processes. Remarkably, Mtrr deficiency in either maternal grandparent resulted in a similar spectrum and frequency of phenotypes in their wild-type grandprogeny. Therefore, the initial effect of Mtrr deficiency is likely transmitted through the germline via epigenetic factors, independent of physiological environment and genomic sequence. The epigenetic influences caused by Mtrr deficiency in mice leads to two distinctive phenotypes: (1) an atypical uterine environment in their wild-type daughters that causes growth defects in their wild-type grandprogeny and (2) congenital malformations in their wild-type grandprogeny due to epigenetic inheritance via the germline, the effects of which persist for at least up to four wild-type generations after an Mtrr-deficient maternal ancestor. Because the folate pathway donates methyl groups necessary for cellular methylation, DNA methylation was a likely epigenetic candidate. Human polymorphisms in folate metabolic enzymes (e.g., MTHFR 677C/T) (Castro et al., 2004; Friso et al., 2002) or the reduction of maternal dietary nutrients (e.g., folate) during periconceptual periods in sheep (Sinclair et al., 2007 ) also result in hypomethylated or demethylated DNA in the immediate offspring's genome. However, none of these studies assessed whether these effects were transmitted to subsequent generations. Changes in histone methylation are less likely than changes in DNA methylation to explain the grandparental origin effects simply because histones are largely replaced by protamine proteins during spermatogenesis (Agell et al., 1983) .
The widespread dysregulation of DNA methylation in the Mtrr gt model likely explains the wide spectrum of phenotypes observed in the wild-type grandprogeny. Knocking out DNA methyltransferases in conceptuses causes extensive DNA demethylation and phenotypes, including growth restriction, developmental delay, NTDs, placental defects, and embryonic lethality (Hata et al., 2002; Li et al., 1992; Okano et al., 1999) . These phenotypes are reminiscent of those observed in our study and imply that folate plays an important epigenetic role during development. Using imprinted loci as a model for the entire genome, we were able to show extensive epigenetic instability associated with gene misexpression specifically in placentas of the wildtype grandprogeny. At many of the loci assessed, the placentas exhibited locus-specific hypermethylation in the context of global DNA hypomethylation, which is similar to the Mthfr À/À mouse that also has locus-specific methylation trends that do not reflect genome-wide methylation trends (Chan et al., 2010; Chen et al., 2001 ). The mechanism behind this finding is unknown. Because the Mtrr gt line was extensively backcrossed to sustain genetic robustness, it was impossible to determine the parental origin of imprinted alleles. Regardless, it is unlikely that the alterations in DNA methylation profiles are attributed to a failure to establish parental imprints but rather are attributed to an inability to maintain genome-wide DNA methylation patterns in imprinted and nonimprinted genes alike. This might be a consequence of reduced methyl group availability or dysregulation of methylation maintenance machinery.
We showed that congenital abnormalities in the Mtrr gt model are caused by transgenerational epigenetic inheritance because these phenotypes persist for four wild-type generations after the initial Mtrr gt ancestor and occur after embryo transfer. The genetic background of the Mtrr gt mouse line is an unlikely cause of the congenital abnormalities because these defects were never observed in the C57Bl/6 control pedigree. Although the mechanism behind epigenetic inheritance remains unknown, we hypothesize that some of the aberrant methylation patterns (epimutations) caused by Mtrr deficiency escape classical epigenetic reprogramming between generations when the genome normally undergoes widespread demethylation. Given the pedigree complexity, interindividual variation in methylation, and wide spectrum of phenotypes observed here, it will be a challenge to identify the precise epimutations that are inherited and that cause specific phenotypes in the Mtrr model. Moreover, it is unclear whether the epigenome is able to stabilize in the generations following an Mtrr gt mutant. In an environmental model of transgenerational epigenetic inheritance (Anway et al., 2005) , DNA methylation defects persisted longer than the phenotype (Stouder and Paoloni-Giacobino, 2010) . Therefore, once an epigenetic defect is generated, it may never completely revert back to the ancestral state. This concept has important evolutionary implications.
It is unlikely that the transgenerational effects observed here are due to a cytoplasmically inherited factor such as a virus, prion, or mycoplasma present in the embryonic stem cells used to generate the Mtrr gt mouse line. This is because we have preliminary data from two other independently derived Mtrr mutant mouse lines showing similar developmental effects as Mtrr gt mice at E10.5, including developmental delay, neural tube, and heart defects in their wild-type grandprogeny (D.J., X. Zhao, J.C.C., and R.A.G., unpublished data). Other mechanisms of transgenerational epigenetic effects include the inheritance of small noncoding RNAs as shown in C. elegans (Grishok et al., 2000; Vastenhouw et al., 2006) . The Mtrr gt mouse model will be extremely useful for future studies on the mechanisms of transgenerational inheritance, including the inheritance of epimutations and small noncoding RNA.
Our finding of a grandparental, but not a direct maternal, effect of abnormal folate metabolism appears to differ from another study that used an independently derived Mtrr gt mouse line (Deng et al., 2008) . Deng et al. (2008) attributed small embryo size and a ventricular septal defect in embryos at E14.5 to a maternal effect. We ruled out a direct maternal effect at least at E10.5 when we systematically controlled for the grandparental genotypes because conceptuses from Mtrr
, Mtrr +/gt , and Mtrr gt/gt mothers were similarly affected. The difference may be
due to yet-to-be explained genetic or metabolic differences or to different stages of analysis. Gross assessment of our conceptuses at E14.5 showed few overt embryonic abnormalities, suggesting that the severely affected conceptuses die between E10.5 and E14.5 (N.P. and E.D.W., unpublished data). Overall, our studies have important consequences for understanding and treating congenital anomalies in humans. First, hypomorphic mutations in the MTRR gene associated with reduced expression may lead to congenital abnormalities, even with normal dietary folate. Second, the transgenerational effect of Mtrr deficiency in mice suggests that the full beneficial impact of folate fortification in humans may take more than one generation to observe and that grandparental polymorphisms in folate metabolism pose a risk.
EXPERIMENTAL PROCEDURES Mice and Dissections
Embryonic stem cells with Mtrr gt allele (XG334) were purchased from BayGenomics (http://www.mmrrc.org/catalog/overview_BG.php) and injected into C57Bl/6 blastocysts using standard procedures at BayGenomics. After confirmation of germline transmission of Mtrr gt allele, the progeny were backcrossed to C57Bl/6 mice (http://jaxmice.jax.org) R 8 generations to become generation I. Mice in the Mtrr +/gt intercross and maternal effect studies (Figures 2A and S1 and Table S1 ) were backcrossed only six generations. Noon of the day the vaginal plug was detected was considered E0.5. Embryonic somite staging was determined according to e-Mouse Atlas Project (http://www.emouseatlas.org). Conceptuses were scored for phenotypes, photographed, weighed, and snap frozen for storage. All experiments were performed in accordance with the Canadian Council on Animal Care and the University of Calgary Committee on Animal Care (protocol number M06109) and UK Government Home Office licensing procedures.
Diet
Mice were fed a normal breeding diet ad libitum from weaning onward. For more information, see the Extended Experimental Procedures and Table S4 . (C-E) CpG site-specific methylation (mean ± SEM) in the DMRs of (C) Gpr1/Zdbf2, (D) Igf2/H19, and (E) Grb10 loci as determined by pyrosequencing followed by the relative RNA levels (mean ± SEM) of the imprinted genes controlled by these DMRs. Values were compared to C57Bl/6 controls. Statistical analysis: for DNA methylation, nonparametric Mann-Whitney test comparing methylation percentages at each CpG site to C57Bl/6; for gene expression, independent t tests were used to compare each phenotype/pedigree to C57Bl/6. *p < 0.05, **p < 0.01, and ***p < 0.005. See also Figure S4 and Tables S3 and S5. ACTTCCGGAGCGGATCTC), which annealed to the gt, detected the mutant band (383 bp). PCR parameters: 30 s at 95 C, 1 min at 62 C, and 1 min at 72 C for 30 cycles. DNA samples were obtained from ear or yolk sac tissue.
DNA and RNA Extraction
For Mtrr transcript analysis, total RNA extraction from adult organs was completed using TRIzol reagent according to manufacturer's instructions (Invitrogen). For transcript analysis of imprinted genes, whole placentas and embryos at E10.5 were homogenized using lysing matrix D beads (MP Biomedicals). Total RNA extraction was completed using the GenElute Mammalian Total RNA Miniprep Kit (Sigma) or AllPrep DNA/RNA Mini Kit (QIAGEN). All extracts were treated with DNase I (Fermentas).
qRT-PCR Reverse-transcription reactions were performed with the RevertAid H Minus First Strand complementary DNA (cDNA) Synthesis Kit (Fermentas) by using 2-5 mg of RNA in a 20 ml reaction according to manufacturer's instructions. PCR amplification was conducted using MESA SYBR Green qPCR MasterMix Plus (Eurogentec) on an Applied Biosystems 7500 system or a Roche LightCycler 480 System. Transcript levels were normalized to Actb and/or Hprt RNA levels, and the fold change was quantified using the standard curve method. cDNA levels in C57Bl/6 placentas were normalized to 1. Experiments were conducted in triplicate with at least three biological replicates. For primer sequences, refer to Table S5 .
Total Homocysteine Concentrations
Total homocysteine in plasma was measured by the Biochemical Genetics Unit, Department of Clinical Biochemistry, Cambridge University Hospitals NHS Foundation Trust using underivatized LC-MS/MS (Waters Acquity LC system and Quattro Premiere mass spectrometer) operated in electrospray ionization positive mode. A deuterated internal standard, d8-homocystine, was added to the plasma, followed by reduction of disulfides with dithiothreitol (Magera et al., 1999; Weaving et al., 2006) . Calibrators were prepared by spiking normal plasma with a range of known homocysteine concentrations. Fifty mL of d8-homocystine was added to 50 ml of plasma, which, when reduced, gave twice as much homocysteine. The mixture was reduced with dithiothreitol, and proteins were precipitated with acetonitrile and 0.1% formic acid. The samples were centrifuged and transferred to 96-well plates, and the supernatant was injected into the tandem mass spectrometer via a cyano LC column (Supelcosil LC-CN). Multiple reaction monitoring (MRM) was used to quantify the total homocysteine against a standard curve. Quality control samples were run at two levels in every batch, which had designed acceptance limits before the results were accepted.
DNA Methylation Analysis
Tissue was snap frozen immediately after phenotypic scoring and stored at À80 C. DNA extraction from all samples occurred simultaneously to reduce sample variability. Global DNA methylation was measured using the SuperSense Methylated DNA Quantification Kit (Epigentek) or the MethylFlash Methylated DNA Quantification Kit (Fluorometric) (Epigentek) according to manufacturer's instructions. Briefly, genomic DNA extracted from tissue was exposed to a fluorescently labeled antibody against 5-methylcytosine (5mC), and the fluorescence intensity was quantified with a FLUOstar OPTIMA fluorescence plate reader (BMG LABTECH) at 540 EX /590 EM nm. Global 5mC levels were calculated as a percentage of total cytosine in DNA and normalized to 1. Four to eight biological replicates were used per category tested. To measure relative CpG methylation at imprinted DMRs, genomic DNA was bisulphite treated using an Imprint DNA Modification Kit (Sigma). 50 ng of bisulphite-converted DNA was used as a template for PCR, together with 0.2 mM of each biotinylated primer and 0.25 units of HotStarTaq DNA Polymerase (QIAGEN) or TrueStart* Taq DNA Polymerase (Fermentas). Refer to See also Figure S5 . purified using Streptavidin Sepharose High Performance columns (GE Healthcare) and hybridized to the sequencing primer using a PyroMark Q96 Vacuum Prep Workstation (QIAGEN). Further sequencing was performed using the PyroMark Gold Reagents kit (QIAGEN) on a PyroMark MD Pyrosequencing System (QIAGEN). The mean CpG methylation was calculated using at least four biological replicates and two technical replicates.
Embryo Transfers
Using M2 media (M7167, Sigma), embryos were flushed at E3.25 from uteri of Mtrr +/+ females (derived from one Mtrr +/gt parent) mated with C57Bl/6 males.
No hormones were used. The embryos were cultured in KSOM (MR-121-D, Millipore) microdrops covered with mineral oil (ES-005-C, Millipore) at 37 C for no more than 30 min before transferring them into uteri of E2.5 pseudopregnant [C57Bl/6 x DBA/2] F1 hybrid (B6D2F1) recipient females (http://www.criver. com). C57Bl/6 embryos were transferred as controls. B6D2F1 females, which have 50% genetic similarity to C57Bl/6 mice, were used because C57Bl/6 mice are notoriously poor recipients. Donor and recipient females were 7-10 weeks old. Embryos were transferred regardless of appearance, and litters were never pooled. Transferred litters were dissected at E10.5, the timing of which corresponded to the staging of the recipient female (Ueda et al., 2003) .
Statistical Analysis
Statistical analyses were performed using GraphPad Prism 6 software. Parametric data (e.g., litter sizes, mRNA expression, homocysteine concentrations, embryo lengths, placenta weights, and global DNA methylation levels) were analyzed using independent unpaired t tests. Global DNA methylation percentages were normalized by arc sine transformation prior to t tests. Nonparametric data (e.g., phenotypic frequencies and bisulfite pyrosequencing data) were analyzed using a Mann-Whitney or Kruskal-Wallis test. p < 0.05 was considered significant.
Equipment and Software
A Zeiss SteREO Discovery V8 microscope with an AxioCam MRc5 camera and AxioVision 4.7.2 software (Carl Zeiss) imaging software program were used to obtain embryo images and embryo crown-rump lengths. PCR and pyrosequencing primers were designed using Primer3 v0.4.0 software (Rozen and Skaletsky, 2000) and Pyromark Assay Design 2.0 software (QIAGEN), respectively. Graphs were generated using GraphPad Prism 6 software. Figures were constructed using Canvas X software. ) as the average number of phenotypically affected conceptuses/litter (± SEM) for each pedigree followed by the percentage of total conceptuses in brackets. Phenotypic frequencies/pedigree were independently compared to C57Bl/6 using Mann-Whitney test. *p < 0.05, **p < 0.01, and ***p < 0.001. See also Figure S6 .
SUPPLEMENTAL INFORMATION
